What question did this study set out to answer?

The aim is to assess the implications of myocarditis and MYL2 mutation on ventricular tachycardia in young athletes.

⌘+K

April 21, 2026Open Access

Ventricular Tachycardia in a Young Athlete With Prior Myocarditis and MYL2 Mutation

Key Result

Myocarditis may unmask occult genetic substrates such as MYL2 mutations, requiring individualized shared decision-making for return-to-play decisions in young athletes.

Key Points

The aim is to assess the implications of myocarditis and MYL2 mutation on ventricular tachycardia in young athletes.
Analyzed case details of a young athlete with ventricular tachycardia and previous myocarditis.
Evaluated genetic factors, particularly the MYL2 mutation, in the context of myocarditis.
Ventricular tachycardia was diagnosed in the athlete with a history of myocarditis.
The MYL2 mutation was identified as a potential risk factor for cardiac events.

Structured PICO

Population

A young athlete with prior myocarditis and MYL2 mutation

Highlights the complexity of return-to-play decisions in athletes with prior myocarditis and underlying genetic mutations.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Myocarditis may unmask occult genetic substrates, and return-to-play decisions require individualized shared decision-making in the context of incomplete risk data.